As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Bio-IT World Conference an Expo – 2019
Booth #638 | April 15-18, 2019 | Boston, MA read more
Study Data Integration & Search (SDIS™) Demo
PointCross Life Sciences SDIS is the first solution of its kind that closes a major gap in the nonclinical... read more
SEND Data Standardization: Streamlining Nonclinical Study Submissions for FDA Approval
Introduction Regulatory agencies like FDA require all nonclinical study data submitted for IND or NDA submissions to be in CDISC... read more
Metadata Repository: Your Strategic Edge in Clinical Development
Most research organizations spend 16-20 weeks setting up each clinical trial. Six of those weeks go to creating SDTM... read more